Introduced:
Mar 25, 2025
Policy Area:
Health
Congress.gov:
Bill Statistics
3
Actions
1
Cosponsors
0
Summaries
1
Subjects
1
Text Versions
Yes
Full Text
AI Summary
AI Summary
No AI Summary Available
Click the button above to generate an AI-powered summary of this bill using Claude.
The summary will analyze the bill's key provisions, impact, and implementation details.
Error generating summary
Latest Action
Mar 25, 2025
Referred to the House Committee on Energy and Commerce.
Actions (3)
Referred to the House Committee on Energy and Commerce.
Type: IntroReferral
| Source: House floor actions
| Code: H11100
Mar 25, 2025
Submitted in House
Type: IntroReferral
| Source: Library of Congress
| Code: H11100
Mar 25, 2025
Submitted in House
Type: IntroReferral
| Source: Library of Congress
| Code: 1025
Mar 25, 2025
Subjects (1)
Health
(Policy Area)
Cosponsors (1)
(R-FL)
Mar 25, 2025
Mar 25, 2025
Full Bill Text
Length: 5,678 characters
Version: Introduced in House
Version Date: Mar 25, 2025
Last Updated: Nov 13, 2025 6:38 AM
[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H. Res. 253 Introduced in House
(IH) ]
<DOC>
119th CONGRESS
1st Session
H. RES. 253
Expressing support for the designation of May 15, 2025, as ``Prader-
Willi Syndrome Awareness Day'' to raise awareness of and promote
research on the disorder.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
March 25, 2025
Mr. Tonko (for himself and Ms. Salazar) submitted the following
resolution; which was referred to the Committee on Energy and Commerce
_______________________________________________________________________
RESOLUTION
Expressing support for the designation of May 15, 2025, as ``Prader-
Willi Syndrome Awareness Day'' to raise awareness of and promote
research on the disorder.
Whereas Prader-Willi syndrome
(PWS) is a rare genetic disorder and the most
common of the genetic disorders that cause life-threatening obesity in
children;
Whereas PWS usually results from problems on chromosome 15;
Whereas PWS is a complex genetic disorder that occurs in approximately 1 out of
every 15,000 births;
Whereas, in the United States, there are approximately 10,000 to 20,000 living
individuals with PWS;
Whereas PWS affects--
(1) males and females with equal frequency; and
(2) all races and ethnicities;
Whereas PWS causes an extreme and insatiable appetite, often resulting in severe
obesity;
Whereas severe obesity is the major cause of death for individuals with PWS;
Whereas one of the main symptoms of PWS is the inability to control eating and
constant hunger, and other symptoms include low muscle tone and poor
feeding as an infant, delays in intellectual development, and difficulty
controlling emotions;
Whereas PWS causes cognitive and learning disabilities and behavioral
difficulties, including obsessive-compulsive disorder and difficulty
controlling emotions;
Whereas PWS affects many aspects of the person's life, including eating,
behavior and mood, physical growth, and intellectual development;
Whereas PWS can affect hormone production and cause other health complications;
Whereas PWS can lead to obesity and related complications such as heart issues,
diabetes, and high blood pressure;
Whereas studies have shown that individuals with PWS have a high morbidity and
mortality rate;
Whereas individuals with PWS, like many other rare disorders, experience
challenges with obtaining a diagnosis, limited treatment options, and
difficulty finding and accessing treatment centers and physicians with
expertise in PWS;
Whereas there is no known cure for PWS;
Whereas early diagnosis of PWS allows families to access treatment, intervention
services, and support from health professionals, advocacy organizations,
and other families who are dealing with PWS;
Whereas discovered treatments, including the use of human growth hormone, are
improving the quality of life for individuals with the syndrome and
offer new hope to families, but many difficult symptoms associated with
PWS remain untreated;
Whereas increased research into PWS--
(1) may lead to a better understanding of the disorder, more effective
treatments, and an eventual cure for PWS; and
(2) is likely to lead to a better understanding of common public health
concerns, including childhood obesity and mental health;
Whereas there is a critical need for research and development to advance
treatments for PWS;
Whereas studies have shown that individuals with PWS have a high morbidity and
mortality rate;
Whereas the Prader-Willi Syndrome Association, a nonprofit organization
established in 1975, provides parents and health care professionals with
a national and international network of information, support services,
and research endeavors to expressly meet the needs of children and
adults with PWS and their families;
Whereas the organization comprises parents, professionals, and other interested
individuals who are taking active roles in improving the lives of people
with PWS;
Whereas the goals of the organization include--
(1) normalizing life for people with PWS and their families;
(2) improving communication and education; and
(3) acting as a lifetime advocate for affected individuals;
Whereas the association also supports research, interdisciplinary communication,
and increased professional knowledge of treatments; and
Whereas ``Prader-Willi Syndrome Awareness Day'' is expected to be observed in
the United States for years to come, providing hope and information for
patients, caregivers, and families around the country: Now, therefore,
be it
Resolved, That the House of Representatives--
(1) supports the designation of ``Prader-Willi Syndrome
Awareness Day'';
(2) applauds the efforts of advocates and organizations
that encourage awareness, promote research, and provide
education, support, and hope to those impacted by Prader-Willi
syndrome;
(3) recognizes the commitment of parents, families,
researchers, health professionals, and others dedicated to
finding an effective treatment and eventual cure for Prader-
Willi syndrome; and
(4) recognizes the importance of, with respect to Prader-
Willi syndrome--
(A) improving awareness and educating the public;
(B) encouraging accurate and early diagnosis;
(C) advancing research;
(D) developing new treatments, diagnostics, and
cures; and
(E) identifying regulatory pathways for drug
development of rare diseases like Prader-Willi
syndrome.
<all>
[From the U.S. Government Publishing Office]
[H. Res. 253 Introduced in House
(IH) ]
<DOC>
119th CONGRESS
1st Session
H. RES. 253
Expressing support for the designation of May 15, 2025, as ``Prader-
Willi Syndrome Awareness Day'' to raise awareness of and promote
research on the disorder.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
March 25, 2025
Mr. Tonko (for himself and Ms. Salazar) submitted the following
resolution; which was referred to the Committee on Energy and Commerce
_______________________________________________________________________
RESOLUTION
Expressing support for the designation of May 15, 2025, as ``Prader-
Willi Syndrome Awareness Day'' to raise awareness of and promote
research on the disorder.
Whereas Prader-Willi syndrome
(PWS) is a rare genetic disorder and the most
common of the genetic disorders that cause life-threatening obesity in
children;
Whereas PWS usually results from problems on chromosome 15;
Whereas PWS is a complex genetic disorder that occurs in approximately 1 out of
every 15,000 births;
Whereas, in the United States, there are approximately 10,000 to 20,000 living
individuals with PWS;
Whereas PWS affects--
(1) males and females with equal frequency; and
(2) all races and ethnicities;
Whereas PWS causes an extreme and insatiable appetite, often resulting in severe
obesity;
Whereas severe obesity is the major cause of death for individuals with PWS;
Whereas one of the main symptoms of PWS is the inability to control eating and
constant hunger, and other symptoms include low muscle tone and poor
feeding as an infant, delays in intellectual development, and difficulty
controlling emotions;
Whereas PWS causes cognitive and learning disabilities and behavioral
difficulties, including obsessive-compulsive disorder and difficulty
controlling emotions;
Whereas PWS affects many aspects of the person's life, including eating,
behavior and mood, physical growth, and intellectual development;
Whereas PWS can affect hormone production and cause other health complications;
Whereas PWS can lead to obesity and related complications such as heart issues,
diabetes, and high blood pressure;
Whereas studies have shown that individuals with PWS have a high morbidity and
mortality rate;
Whereas individuals with PWS, like many other rare disorders, experience
challenges with obtaining a diagnosis, limited treatment options, and
difficulty finding and accessing treatment centers and physicians with
expertise in PWS;
Whereas there is no known cure for PWS;
Whereas early diagnosis of PWS allows families to access treatment, intervention
services, and support from health professionals, advocacy organizations,
and other families who are dealing with PWS;
Whereas discovered treatments, including the use of human growth hormone, are
improving the quality of life for individuals with the syndrome and
offer new hope to families, but many difficult symptoms associated with
PWS remain untreated;
Whereas increased research into PWS--
(1) may lead to a better understanding of the disorder, more effective
treatments, and an eventual cure for PWS; and
(2) is likely to lead to a better understanding of common public health
concerns, including childhood obesity and mental health;
Whereas there is a critical need for research and development to advance
treatments for PWS;
Whereas studies have shown that individuals with PWS have a high morbidity and
mortality rate;
Whereas the Prader-Willi Syndrome Association, a nonprofit organization
established in 1975, provides parents and health care professionals with
a national and international network of information, support services,
and research endeavors to expressly meet the needs of children and
adults with PWS and their families;
Whereas the organization comprises parents, professionals, and other interested
individuals who are taking active roles in improving the lives of people
with PWS;
Whereas the goals of the organization include--
(1) normalizing life for people with PWS and their families;
(2) improving communication and education; and
(3) acting as a lifetime advocate for affected individuals;
Whereas the association also supports research, interdisciplinary communication,
and increased professional knowledge of treatments; and
Whereas ``Prader-Willi Syndrome Awareness Day'' is expected to be observed in
the United States for years to come, providing hope and information for
patients, caregivers, and families around the country: Now, therefore,
be it
Resolved, That the House of Representatives--
(1) supports the designation of ``Prader-Willi Syndrome
Awareness Day'';
(2) applauds the efforts of advocates and organizations
that encourage awareness, promote research, and provide
education, support, and hope to those impacted by Prader-Willi
syndrome;
(3) recognizes the commitment of parents, families,
researchers, health professionals, and others dedicated to
finding an effective treatment and eventual cure for Prader-
Willi syndrome; and
(4) recognizes the importance of, with respect to Prader-
Willi syndrome--
(A) improving awareness and educating the public;
(B) encouraging accurate and early diagnosis;
(C) advancing research;
(D) developing new treatments, diagnostics, and
cures; and
(E) identifying regulatory pathways for drug
development of rare diseases like Prader-Willi
syndrome.
<all>